• Search
  • Helpdesk
  • Sales contact

eCOA in ophthalmology

Last updated : June 24, 2024

There is an extended use of Patient Reported Outcome (PRO) measures in clinical trials used to assess health-related quality of life, symptoms, or perception of health status by the patients participating in clinical research. These measures are increasingly being collected via electronic devices and are, as such, referred to as ePROs.

In ophthalmology trials, the types of ePRO used can be general (SF-36, EQ-5D), vision specific (VFQ-25) or condition specific (glaucoma utility index, Retinopathy Treatment Satisfaction Questionnaire). A very wide range of validated questionnaires are available for use in research and selecting the right ePRO in an ophthalmology study is paramount to the success of a clinical trial.


Discover the five keys for successful ePRO selection in your ophthalmology clinical trial:

Follow us on LinkedIn to stay up-to-date on our latest videos:

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

5th Annual Clinical Trial Innovation Summit

JUNE 26, 2025 • Basel, CH
Clinical Trial Innovation Summit 2025 | June 26, 2025

The reckless value of Patient Reported Outcomes (PROs) for Emerging Biopharma Companies – Webinar

July 9 • 11-12AM EDT / 4-5PM GMT / 5-6PM CET
In today’s competitive landscape, biotech and emerging biopharma companies (EBPs) must demonstrate the value of their innovations early and convincingly....

DPHARM 2025

SEPT 16-17 2025 • Philadelphia, PA, USA
Booth #44 16th Annual Outsourcing in Clinical Trials East Coast 2025 - Arena International